A new BVDV type I inactivated vaccine (PregSure® BVD): Broad cross neutralisation of type I and type II BVDV strains and significant improvement of pregnancy rates;PregSure® BVD - Eine neue inaktivierte BVD-vakzine: breite kreuzneutralisation von europäischen BVDV-typ-1- und -typ-2-stämmen und signifikante verbesserung der fertilität nach testinfektionen

Tierarztliche Praxis Ausgabe G: Grosstiere - Nutztiere

Volumn 32, Issue 4, 2004, Pages 191-195

  Salt, J S ^a   Antonis, A F G ^b   Peters, A R ^a   Brune, Annette ^c   Jahnecke, S ^c   Traeder, W ^c   Harmeyer, Silke S ^a,d  

^a ZOETIS   (United States)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c PFIZER INC   (United States)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

BVDV type 1, type 2; Challenge; Cross neutralisation; Fertility; Pregnancy losses; Vaccine

Indexed keywords

INACTIVATED VIRUS VACCINE; NEUTRALIZING ANTIBODY; PREGSURE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; ARTIFICIAL INSEMINATION; CATTLE DISEASE; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; FERTILITY; FETUS; IN VITRO STUDY; NONHUMAN; PREGNANCY; PROVOCATION TEST; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALIA; BOS TAURUS; BOVINE VIRAL DIARRHEA VIRUS 1; BOVINE VIRAL DIARRHEA VIRUS 2; MARTES PENNANTI;

EID: 4544333987     PISSN: 14341220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1623556     Document Type: Article

References (15)

1. Becher P, König M, Thiel H-J. Bovine Virusdiarrhö und Mucosal Disease: Molekularbiologie des Erregers, Pathogenese, Labordiagnostik und Bekämpfung. Tierärztl Prax 2001; 29 (G): 266-75.
2. Beer M, Wolf G. Selection of BVDV genotype II isolates using a monoclonal antibody and FACS analysis. Berl Münch Tierärztl Wschr 1999; 112: 345-50.
3. Beer M, Wolf G. Impfstoffe zum Schutz gegen eine Infektion mit dem Virus der Bovinen Virusdiarrhoe/Mucosal Disease (BVD/MD): Eine kurze Übersicht. Berl Münch Tierärztl Wschr 2003; 116: 252-8.
4. Fairbanks K, Schnackel J, Chase CC. Evaluation of a modified live virus type-1a bovine viral diarrhoea virus vaccine (Singer strain) against a type-2 (strain 890) challenge. Vet Ther 2003; 4: 24-34.
5. Fulton RW, Ridpath JF, Confer AW, Saliki JT, Burge LJ, Payton ME. Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programmes. Biologicals 2003; 31: 89-95.
6. Hamers C, Couvreur B, Dehan P, Letellier C, Fischer L, Brun AJ, Lewalle P, Mischaux C, Pastoret PP, Kerkhofs P. Assessment of the clinical and virological protection provided by a commercial inactivated bovine viral diarrhoea virus genotype 1 vaccine against a BVDV genotype 2 challenge. Vet Rec 2003; 153: 236-40.
7. Houe H. Economic impact of BVDV infection in dairies. Biologicals 2003; 31: 137-43.
8. König M, Sedillo Rosales S, Becher P, Thiel HJ. Heterogenität ruminanter Pestiviren: Akademisches Interesse oder wichtige Grundlage für die Entwicklung von Impfstoffen und Diagnostika? Berl Münch Tierärztl Wschr 2003; 116: 216-21.
9. Kuchenbuch S. Reproductive management in dairy heifers: Comparison of timed artificial insemination and insemination on observed estrus. Diss med vet, Freie Universität Berlin 2002.
10. Moerman A, Straver PJ, de Jong MC, Quak J, Baanvinger T, van Oirschot JT. Clinical consequences of a bovine virus diarrhoea virus infection in a dairy herd: a longitudinal study. Vet Quart 1994; 16: 115-9.
11. Paton DJ, Sharp G, Ibata G. Foetal cross-protection experiments between type 1 and type 2 bovine viral diarrhoea virus in pregnant ewes. Vet Microbiol 1999; 64: 185-96.
12. Robert A, Beaudeau F, Seegers H, Joly A, Philipot JM. Large scale assessment of the effect associated with bovine viral diarrhoea virus infection on fertility of dairy cows in 6149 herds in Brittany (Western France). Theriogenology 2004; 61: 117-27.
13. Tajima M, Frey HR, Yamato O, Maede Y, Moennig V, Scholz H, Greiser-Wilke I. Prevalence of genotypes 1 and 2 of bovine viral diarrhea virus in Lower Saxony, Germany. Virus Res 2001; 76: 31-42.
14. Vilcek S, Paton DJ, Durkovic R, Strojny L, Ibata G, Moussa A, Loitsch A, Rossmanith W, Vega S, Scicluna MT, Palfi V. Bovine viral diarrhoea virus genotype 1 can be separated into at least eleven genetic groups. Arch Virol 2001; 146: 99-115.
15. Wolfmeyer A, Wolf G, Beer M, Strube W, Hehnen HR, Scbmeer N, Kaaden OR. Genomic (5′UTR) and serological differences among German BVDV field isolates. Arch Virol 1997; 142: 2049-57.